MedTrace Logo

Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff

NCT04495036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 683

Last updated 2020-08-04

No results posted yet for this study

Summary

This study is to investigate the current use and intention to use of teledermatology in Swiss dermatology patients, dermatologists, other physicians and medical staff.

Conditions

  • Dermatologic Disease

Interventions

OTHER

data collection (21-items-patient descriptive survey)

Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed: * Demographic data of telemedicine users and non-users * Subjective disease perception of the dermatology patients * Use of internet, telemedicine and telemedicine insurance model * Patients´ willingness for additional features of telemedicine * Advantages and disadvantages telemedicine and face-to-face consultation * Suitable fields of dermatology for telemedicine from the patient's perspective * Recommended structure of telemedical services by users and non-users

OTHER

data collection (23-items-physician descriptive survey)

To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed: * Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease) * Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Lara Valeska Maul, Dr. med. · Department of Dermatology, University Hospital Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495036 on ClinicalTrials.gov